PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL) will unveil the latest additions to its extensive portfolio of advanced filtration and purification products designed to enable the ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE:PLL) today announced a major advance in nuclear power plant filtration with the launch of a filter that reduces radioactive particulate ...
New pilot program targets a flue-gas pre-treatment bottleneck that affects carbon capture reliability, cost, and scalability Supported by $1 million CAD in funding from Emissions Reduction Alberta ...
PORT WASHINGTON, N.Y., April 20, 2010 - The sensitive and accurate testing of process membrane filter integrity is critical to ensuring efficient, safe pharmaceutical production and regulatory ...
PORT WASHINGTON, N.Y., Feb. 3, 2026 /PRNewswire/ -- Pall Corporation, a global leader in filtration, separation and purification, and Emirates Airline are celebrating a decade-long partnership that ...
Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the launch of the Leukotrap® Affinity Plus Prion and Leukocyte Reduction Filter System. The ...
PORT WASHINGTON, N.Y., Jan. 11, 2022 /PRNewswire/ -- Pall Corporation, a leader in filtration, separation and purification technology and a Danaher operating company, launched the new SupralonTM ...
PORT WASHINGTON, N.Y., February 02, 2010 - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation ...
A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation (NYSE: PLL) can reduce severe complications and the length of a patient's stay in the pediatric ...
East Hills, NY (Dec. 6, 2005) - - Municipal and community water providers are racing to meet the U.S. Environmental Protection Agency's (EPA) January 23, 2006 deadline for reducing arsenic in drinking ...
Deal includes equipment for transfusion medicine and production plants. Pall is selling certain assets of its blood collection, filtration, and processing product lines to Haemonetics for roughly $550 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results